Patents by Inventor Beverly C. LANGEVIN

Beverly C. LANGEVIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF
    Publication number: 20230285334
    Abstract: Provided herein are compositions, formulations, and (e.g., oral) dosage forms comprising a compound of Formula (I). In specific instances, such compositions comprise an emulsifier, a solubilizer, a polyethylene glycol, a surfactant, and an antioxidant. In some instances, such compositions are useful for the treatment of fibrosis, cancer, and/or chronic inflammation.
    Type: Application
    Filed: November 28, 2022
    Publication date: September 14, 2023
    Inventors: Imran Alibhai, Sofia de Achaval, Beverly C. Langevin, Tian Zhou
  • Therapeutic compounds, formulations, and uses thereof
    Patent number: 11547683
    Abstract: Provided herein are compositions, formulations, and (e.g., oral) dosage forms comprising a compound of Formula (I). In specific instances, such compositions comprise an emulsifier, a solubilizer, a polyethylene glycol, a surfactant, and an antioxidant. In some instances, such compositions are useful for the treatment of fibrosis, cancer, and/or chronic inflammation.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: January 10, 2023
    Assignee: Tvardi Therapeutics, Inc.
    Inventors: Imran Alibhai, Sofia De Achaval, Beverly C. Langevin, Tian Zhou
  • THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF
    Publication number: 20210322347
    Abstract: Provided herein are compositions, formulations, and (e.g., oral) dosage forms comprising a compound of Formula (I). In specific instances, such compositions comprise an emulsifier, a solubilizer, a polyethylene glycol, a surfactant, and an antioxidant. In some instances, such compositions are useful for the treatment of fibrosis, cancer, and/or chronic inflammation.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Inventors: Imran Alibhai, Sofia De Achaval, Beverly C. Langevin, Tian Zhou
  • Therapeutic compounds, formulations, and uses thereof
    Patent number: 11077077
    Abstract: Provided herein are compositions, formulations, and (e.g., oral) dosage forms comprising a compound of Formula (I). In specific instances, such compositions comprise an emulsifier, a solubilizer, a polyethylene glycol, a surfactant, and an antioxidant. In some instances, such compositions are useful for the treatment of fibrosis, cancer, and/or chronic inflammation.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: August 3, 2021
    Assignee: Tvardi Therapeutics, Inc.
    Inventors: Imran Alibhai, Sofia De Achaval, Beverly C. Langevin, Tian Zhou
  • THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF
    Publication number: 20210228512
    Abstract: Provided herein are compositions, formulations, and (e.g., oral) dosage forms comprising a compound of Formula (I). In specific instances, such compositions comprise an emulsifier, a solubilizer, a polyethylene glycol, a surfactant, and an antioxidant. In some instances, such compositions are useful for the treatment of fibrosis, cancer, and/or chronic inflammation.
    Type: Application
    Filed: March 16, 2021
    Publication date: July 29, 2021
    Inventors: Imran Alibhai, Sofia De Achaval, Beverly C. Langevin, Tian Zhou
  • Fumarate salts of a histamine H3 receptor antagonist
    Patent number: 8664245
    Abstract: The disclosure relates to fumarate salts of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide, to pharmaceutical compositions thereof, processes for making the same, and methods of use thereof.
    Type: Grant
    Filed: December 8, 2011
    Date of Patent: March 4, 2014
    Assignee: Sanofi
    Inventors: Beverly C. Langevin, Robert Allan Farr, Dinubhai H. Shah, Daniel Sherer
  • NOVEL FUMARATE SALTS OF A HISTAMINE H3 RECEPTOR ANTAGONIST
    Publication number: 20120149728
    Abstract: The disclosure relates to fumarate salts of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide, to pharmaceutical compositions thereof, processes for making the same, and methods of use thereof.
    Type: Application
    Filed: December 8, 2011
    Publication date: June 14, 2012
    Applicant: SANOFI
    Inventors: Beverly C. LANGEVIN, Robert Allan FARR, Dinubhai H. SHAH, Daniel SHERER
  • CRYSTALLINE FORMS
    Publication number: 20110257190
    Abstract: The disclosure relates to crystalline forms of 2-[4-(7-ethyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)-phenyl]-propan-2-ol, characterized by physico-chemical data described herein.
    Type: Application
    Filed: June 2, 2011
    Publication date: October 20, 2011
    Applicant: SANOFI
    Inventors: Kenneth J. BORDEAU, Beverly C. LANGEVIN, II, George Everett LEE, Patricia LOGUE, Elizabeth SECORD, Daniel SHERER